Intraoperative Radiation Therapy Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Intraoperative Radiation Therapy Market is Segmented by Method (Electron IORT, Intraoperative Brachytherapy, and Other Methods), Products and Services (Product and Services), Application (Breast Cancer, Brain Tumor, Gastrointestinal Cancer, Head and Neck Cancer, and Other Applications), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Global Intraoperative Radiation Therapy Market Size

Single User License
Team License
Corporate License
Book before:
Intraoperative Radiation Therapy Market Summary
share button
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 6.30 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration High

Major Players

Intraoperative Radiation Therapy Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

OFF

Team License

OFF

Corporate License

OFF
Book before:

Global Intraoperative Radiation Therapy Market Analysis

The intraoperative radiation therapy market is expected to record a CAGR of 6.3% over the forecast period.

COVID-19 significantly impacted the intraoperative radiation therapy market. Various screening, diagnostics, and surgical procedures were restricted or postponed at hospitals and cancer treatment centers, disrupting cancer diagnosis and treatment procedures. As per a research study published in October 2021 by the Journal of Medical Screening, during the pandemic, breast cancer screening was affected globally as many countries such as Canada, the Netherlands, Germany, Italy, the United Kingdom, and Australia halted their breast screening programs in response to COVID-19. Thus, this led to a decline in the diagnosis of cancer and severely impacted the market's growth. However, the market has recovered well due to a decline in COVID-19 cases and the resumption of diagnostic and screening processes globally. It is anticipated to gain traction due to an increase in cancer cases throughout the forecast period.

An increase in the incidence and prevalence of cancer globally is projected to drive the intraoperative radiation therapy market during the forecast period. The most common cancers are breast cancer, lung and bronchus cancer, prostate cancer, colon and rectum cancer, melanoma of the skin, bladder cancer, non-Hodgkin lymphoma, kidney and renal pelvis cancer, endometrial cancer, leukemia, pancreatic cancer, thyroid cancer, and liver cancer. According to the Breast Cancer Factsheet Now 2021, around 55,000 women and 370 men in the United Kingdom are diagnosed with breast cancer every year. This figure is expected to climb to 1.2 million by 2030. Thus, the huge prevalence of cancer cases is likely to increase the demand for radiation therapy, thereby boosting the market's growth over the forecast period.

Besides, increasing demand for highly efficient radiation therapy systems for cancer treatment, new product approvals, and fundraising are projected to augment the intraoperative radiation therapy market during the forecast period. For instance, in October 2022, PLANET successfully raised GBP 1 million for a ground-breaking radiation system to fully purchase Mobetron, a cutting-edge mobile device that administers intraoperative radiotherapy during surgery.

However, the lack of skilled personnel to operate the equipment and preference for conventional radiotherapy over IORT may hinder the market's growth.

Global Intraoperative Radiation Therapy Market Trends

Electron IORT Segment is Expected to Hold Significant Market Share Over the Forecast Period

Electron intraoperative radiation therapy or intraoperative electron radiation therapy (IOERT) is the application of electron radiation directly to the residual tumor or tumor bed during cancer surgery. Electron beams are useful for intraoperative radiation treatment as the dose falls off rapidly behind the target site depending on the electron energy, sparing underlying healthy tissue. Besides, intraoperative radiation therapy revolutionized the traditional model by administering radiation during surgery. It is safer and more accurate and saves considerable time for both the hospital and patients. The clinical data also confirm that successful outcomes with IORT are more consistent. Thus, the positive outcomes associated with the IORT are contributing to the market's growth.

According to the REDECAN study published in November 2022, breast cancer is the most frequent cancer and the primary cause of cancer-related death in women in Spain, with 34,750 women diagnosed with it in 2022. As per the same source, there were 30,948 new cases of lung cancer diagnosed in Spain in 2022. Thus, the huge prevalence of cancer and the need for early diagnostics are expected to increase, supporting the segment's expansion over the forecast period.

Intraoperative Radiation Therapy Market: Estimated Number of New Cancer Cases, By Type, China, 2022

North America Holds Significant Share in the Market and is Expected to Retain the Same Over Forecast Period

North America is expected to dominate the overall intraoperative radiation therapy market throughout the forecast period, attributed to factors such as the increasing prevalence and incidence of cancers. The United States is expected to be the largest market in the region.

The significant burden of cancer is anticipated to drive the demand for radiotherapy in the region. For instance, according to the American Cancer Society's data in January 2023, an estimated 1.95 million new cancer cases are likely to be diagnosed in the United States in 2023, among which prostate cancer is estimated to account for 186,670 new cases, followed by 169,870 cases of lung cancer and 144,490 cases of female breast cancer. According to statistics by the Government of Canada, released in November 2021, about 229,200 Canadians were diagnosed with cancer in 2021, and prostate cancer was the most diagnosed cancer, accounting for 46% of all cancer diagnoses in 2021. Thus, the country's huge incidence and prevalence of cancer are demanding advanced therapeutics treatment, which is further predicted to boost the overall market's growth in the region.

Besides, well-established healthcare infrastructure and market players undertaking various research activities are also contributing to the market's growth. For instance, in September 2021, SkinCure Oncology declared positive results from a clinical trial, showing positive data (99.3% cure rate) for Image-Guided Superficial Radiotherapy (IGSRT) in treating basal cell carcinoma (BCC) and squamous cell carcinoma (SCC).

Hence, due to such factors, North America is anticipated to create opportunities for intraoperative radiation therapy, driving the overall market's growth over the forecast period.

Intraoperative Radiation Therapy Market- Growth Rate by Region

Global Intraoperative Radiation Therapy Industry Overview

The intraoperative radiation therapy market is highly competitive. Major players in the market are implementing various strategies, such as launching new products and focusing on mergers and acquisitions, to consolidate their market positions across the world. Some of the market players are Ariane Medical Systems Ltd, Eckert & Ziegler, Elekta AB Inc., Sensus Healthcare Inc., Sordina IORT Technologies, and Carl Zeiss Meditec AG.

Global Intraoperative Radiation Therapy Market Leaders

  1. Eckert & Ziegler

  2. Carl Zeiss Meditec AG

  3. Sensus Healthcare Inc.

  4. Ariane Medical Systems Ltd

  5. Sordina IORT Technologies

*Disclaimer: Major Players sorted in no particular order

Intraoperative Radiation Therapy Market Concentration
bookmark Need More Details on Market Players and Competitors?
Download PDF

Global Intraoperative Radiation Therapy Market News

  • In March 2022, Zeiss Medical Technology introduced INTRABEAM 600 device to provide Intraoperative Radiation Therapy (IORT) in India. INTRABEAM 600, Zeiss Meditec's IORT device, offers the least disruptive treatment method available to patients diagnosed with early-stage breast cancer.
  • In February 2022, Fortis Cancer Institute announced the installation of Karnataka's first Intraoperative radiotherapy (IORT) system for the treatment of breast cancer.

Intraoperative Radiation Therapy Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Global Prevalence of Cancer

      2. 4.2.2 Advancements in Cancer Therapy Technologies

      3. 4.2.3 Advantages of IORT Over External Beam Radiotherapy

    3. 4.3 Market Restraints

      1. 4.3.1 Limitations of IORT and Shortage of Trained Personnel

      2. 4.3.2 Preference for Conventional Radiotherapy Over Intraoperative Radiation Therapy

    4. 4.4 Industry Attractiveness - Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By Method

      1. 5.1.1 Electron IORT

      2. 5.1.2 Intraoperative Brachytherapy

      3. 5.1.3 Other Methods

    2. 5.2 By Products and Services

      1. 5.2.1 Products

        1. 5.2.1.1 Systems/Accelerators

        2. 5.2.1.2 Applicators and Afterloaders

        3. 5.2.1.3 Treatment Planning Systems

        4. 5.2.1.4 Accessories

      2. 5.2.2 Services

    3. 5.3 By Application

      1. 5.3.1 Breast Cancer

      2. 5.3.2 Brain Tumor

      3. 5.3.3 Gastrointestinal Cancer

      4. 5.3.4 Head and Neck Cancer

      5. 5.3.5 Other Applications

    4. 5.4 By Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Ariane Medical Systems Ltd

      2. 6.1.2 Eckert & Ziegler

      3. 6.1.3 Elekta AB

      4. 6.1.4 GMV Innovating Solutions

      5. 6.1.5 ICAD Inc.

      6. 6.1.6 Intraop Medical Corporation

      7. 6.1.7 Sensus Healthcare Inc.

      8. 6.1.8 Sordina IORT Technologies

      9. 6.1.9 Varian Medical Systems Inc.

      10. 6.1.10 Carl Zeiss Meditec AG

      11. 6.1.11 Isoray Inc.

      12. 6.1.12 Varian Medical Systems

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers- Business Overview, Financials, Products, Strategies, and Recent Developments
bookmark You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Intraoperative Radiation Therapy Industry Segmentation

As per the report's scope, intraoperative radiation therapy (IORT) is an intensive radiation treatment administered during surgery. IORT allows direct radiation to the target area while sparing normal surrounding tissue. IORT is used to treat cancers that are difficult to remove during surgery and when there is a concern that microscopic amounts of cancer may remain.

The intraoperative radiation therapy market is segmented by method (electron iort, intraoperative brachytherapy, and other methods), products and services (product and services), application (breast cancer, brain tumor, gastrointestinal cancer, head and neck cancer, and other applications), and geography (North America, Europe, Asia Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Method
Electron IORT
Intraoperative Brachytherapy
Other Methods
By Products and Services
Products
Systems/Accelerators
Applicators and Afterloaders
Treatment Planning Systems
Accessories
Services
By Application
Breast Cancer
Brain Tumor
Gastrointestinal Cancer
Head and Neck Cancer
Other Applications
By Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
customize-icon Need A Different Region Or Segment?
Customize Now

Intraoperative Radiation Therapy Market Research FAQs

The Intraoperative Radiation Therapy Market is projected to register a CAGR of 6.30% during the forecast period (2024-2029)

Eckert & Ziegler, Carl Zeiss Meditec AG, Sensus Healthcare Inc., Ariane Medical Systems Ltd and Sordina IORT Technologies are the major companies operating in the Intraoperative Radiation Therapy Market.

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).

In 2024, the North America accounts for the largest market share in Intraoperative Radiation Therapy Market.

The report covers the Intraoperative Radiation Therapy Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Intraoperative Radiation Therapy Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Intraoperative Radiation Therapy Industry Report

Statistics for the 2024 Intraoperative Radiation Therapy market share, size and revenue growth rate, created by Mordor Intelligenceā„¢ Industry Reports. Intraoperative Radiation Therapy analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Intraoperative Radiation Therapy Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)